Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Benzimidazothiazole carboxamide compound and application thereof

A kind of imidazo, formamide technology, applied in the field of medicine, can solve the problem of serious drug resistance and other problems

Inactive Publication Date: 2018-05-11
SHENYANG PHARMA UNIVERSITY
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the research and development of this type of drug is also facing many challenges: the problem of drug resistance caused by tumor cell gene mutation is becoming more and more serious; a balance should be sought between multi-target inhibitory effects and highly selective inhibitory effects; preclinical experiments Accurately predict compound toxicity, pharmacokinetic characteristics, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Benzimidazothiazole carboxamide compound and application thereof
  • Benzimidazothiazole carboxamide compound and application thereof
  • Benzimidazothiazole carboxamide compound and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1: Preparation of N-(2-methylphenyl)-3-methylbenzo[4,5]imidazo[2,1-b]thiazole-2-carboxamide (compound X01)

[0023] Step A: Preparation of 2-Mercaptobenzimidazole

[0024] Place o-phenylenediamine (21.61g, 0.20mol), carbon disulfide (18.24g, 0.24mol), sodium carbonate (14.84g, 0.14mol) and 300mL of water in a 500mL eggplant-shaped bottle, and heat to reflux for 7 hours. Cool to room temperature, suction filter, and dry to obtain 29.4 g of white solid, yield 98.0%, m.p.290-292°C (lit.: 303-305°C), ESI-MS (m / z): 151.1 ([M+H ] + );IR(KBr):υ3441,3153,3114,2979,2877,1618,1513,1467,1215; 1 H-NMR (400MHz, DMSO): δ7.10~7.15 (m, 4H), 12.51 (s, 2H).

[0025] Step B: Preparation of ethyl 2-((1H-benzo[d]imidazol-2-yl)mercapto)-3-oxybutanoate

[0026] Put 2-mercaptobenzimidazole (18.00g, 0.12mol), sodium bicarbonate (30.24g, 0.36mol), ethyl 2-chloroacetoacetate (22.96g, 0.14mol) and 200mL of ethanol in a 1000mL eggplant-shaped flask , after stirring at room temperature ...

Embodiment 2

[0032] Example 2: Preparation of N,3-dimethyl-N-phenylbenzo[4,5]imidazo[2,1-b]thiazole-2-carboxamide (compound X02)

[0033] Referring to the preparation method of Example 1, 0.16 g of a white solid was obtained, with a yield of 49%, m.p.: 167-169° C.; IR: (KBr, cm -1 )3444(s), 2924(s), 2854(s), 1638(s), 1455(m), 1383(s), 741(s), 700(s); 1 HNMR(400MHz,DMSO):δ2.75(s,3H,CH 3 ),3.40(s,3H,CH 3 ),7.22-7.26(m,1H,Ar-H),7.28-7.31(m,1H,Ar-H),7.32-7.36(m,1H,Ar-H),7.38(d,4H,Ar-H , J=4.3Hz), 7.64 (d, 1H, Ar-H, J=8.0Hz), 7.93 (d, 1H, Ar-H, J=8.0Hz); ESI-MS (m / z): 322.0 ( [M+H] + ).

Embodiment 3

[0034] Example 3: Preparation of 3-methyl-N-(3-nitrophenyl)benzo[4,5]imidazo[2,1-b]thiazole-2-carboxamide (compound X03)

[0035] Referring to the preparation method of Example 1, 0.07 g of a white solid was obtained, with a yield of 20%, m.p.: 258-260° C.; IR: (KBr, cm -1 )3441(s), 2924(s), 2853(s), 1637(s), 1456(m), 1384(s), 736(s), 620(s); 1 HNMR(400MHz,DMSO):δ3.09(s,3H,CH 3 ),7.32-7.36(m,1H,Ar-H),7.41-7.45(m,1H,Ar-H),7.69(t,1H,Ar-H,J=8.2Hz),7.75(d,1H, Ar-H, J=8.1Hz), 8.01(dd, 1H, Ar-H, J=8.1, 1.8Hz), 8.11(dd, 2H, Ar-H, J=8.1, 2.4Hz), 8.68(t, 1H, Ar-H, J=2.1Hz), 10.74 (s, 1H, NH); ESI-MS (m / z): 350.7 ([M-H] - ).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicines, and relates to benzimidazothiazole carboxamide compound and application thereof. The benzimidazothiazole carboxamide compound comprises derivatives and pharmaceutically acceptable salts of the benzimidazothiazole carboxamide compound, and the general structure of benzimidazothiazole carboxamide compound is as shown in the description, wherein R1 and R2 are as described in the claims and the description. The benzimidazothiazole carboxamide compound and pharmaceutically acceptable acid addition salts of the benzimidazothiazole carboxamide compound can be combined with existing drugs or used alone as an epidermal growth factor tyrosine kinase inhibitor for treating associated diseases caused by transduction disorder of epidermal growth factor receptor signals such as small cell lung cancer, squamous cell carcinoma, adenocarcinoma, large cell carcinoma, colorectal cancer, mammary cancer, ovarian cancer and renal cell carcinoma.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to benzimidazolothiazole carboxamide compounds and their application as epidermal growth factor receptor tyrosine kinase inhibitors, and a preparation method thereof. Background technique [0002] For a long time, tumor treatment has been a worldwide problem and has become an important challenge in the field of medical research. In recent years, with the further elucidation of tumor pathogenesis and the continuous discovery of anti-tumor targets, protein tyrosine kinase (PTK) has become one of the most effective and promising anti-tumor drug targets. [0003] Epidermal growth factor receptor (EGFR) is a transmembrane protein with both an extramembrane ligand receptor binding domain and an intracellular tyrosine kinase activity domain. The EGFR family mainly includes four types of members: EGFR / ErbB-1, HER-2 / ErbB-2, HER-3 / ErbB-3 and HER-4 / ErbB-4. EGFR is widely distributed in the ep...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D513/04A61K31/429A61K31/4439A61K31/5377A61K31/496A61P35/00
CPCC07D513/04
Inventor 胡春邓新山武娇凤徐越徐赫男侯卜赵阳
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com